Wegovy is still covered for heart-attack and stroke risk reduction (BMI 27 or higher with established cardiovascular disease, no diabetes) and for MASH, a fatty liver disease
But it has a lot of therapeutic potential
Tanaka, Y., Iwaya, C., Kawanami, T., Hamaguchi, Y., Horikawa, T., Shigeoka, T., Yanase, T., Kawanami, D., & Nomiyama, T
GLP-1 is a hormone that is naturally produced in the small intestines
That's been shown in clear trials that randomly allocate people to either stay on the drug or go to placebo after they've had some benefit
COMO FAO PARA CONSERV-LO